Is This Pharma Set To Break Out After COPD Drug Approval?
Source: Streetwise Reports (03/15/2024)
Clinical-stage biopharmaceutical company Verona Pharma Plc is looking toward a pivotal year as its new chronic obstructive pulmonary disease (COPD) drug ensifentrine nears possible approval by the FDA. At least two research companies have named it a top pick for 2024.
read more >
This Biotech Is a Potential Disruptor, Expert Says
Source: Chris Temple (03/12/2024)
Chris Temple of The National Investor shares why he believes BetterLife Pharma Inc. is an Immediate Buy.
read more >
Healthcare AI Firm Has 'Bright Future,' Analyst Predicts
Source: Streetwise Reports (03/08/2024)
Canadian artificial intelligence (AI) and machine learning healthcare firm Treatment.com AI is breaking into the global healthcare AI market predicted to be worth US$187 billion by the end of the decade.
read more >
NY Biotech Has Potentially Game Changing Anxiety Therapy
Source: Dr. Jonathan Aschoff (03/07/2024)
Mind Medicine (MindMed) Inc. recently announced positive results from its Phase 2b trial of MM120 in generalized anxiety disorder, according to a Roth MKM research note.
read more >
Bionic Medical Co. Has Sufficient Funds to Operate Through 2024
Source: Dr. Swayampakula Ramakanth (03/05/2024)
Ekso Bionics Holdings Inc.'s fourth quarter of 2023 financial results were in line with estimates, according to H.C. Wainwright & Co.
read more >